CareFusion Corp (CFN): Today's Featured Health Services Loser
CareFusion (CFN) pushed the Health Services industry lower today making it today's featured Health Services loser. The industry as a whole closed the day down 2.9%. By the end of trading, CareFusion fell 96 cents (-3.8%) to $24.64 on average volume. Throughout the day, 1.8 million shares of CareFusion exchanged hands as compared to its average daily volume of 2.4 million shares. The stock ranged in price between $24.54-$25.16 after having opened the day at $24.88 as compared to the previous trading day's close of $25.60. Other company's within the Health Services industry that declined today were: Amedisys Inc (AMED), down 23.4%, BG Medicine Inc (BGMD), down 16.8%, Almost Family Inc (AFAM), down 14.4%, and Bio-Reference Labs Inc (BRLI), down 12.1%. CareFusion Corporation, a medical technology company, provides various healthcare products and services in the United States and internationally. It operates in two segments, Critical Care Technologies, and Medical Technologies and Services. CareFusion has a market cap of $5.5 billion and is part of the health care sector. The company has a P/E ratio of 20.1, below the average health services industry P/E ratio of 22.7 and above the S&P 500 P/E ratio of 17.7. Shares are up 1.1% year to date as of the close of trading on Monday. TheStreet Ratings rates CareFusion as a hold. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income and revenue growth. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.
- You can view the full CareFusion Ratings Report.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about CFN
-
Markets Close Higher as Bernanke Signals Support
04:42PM 05/10/13
-
A Lower Stock Price Never Turns A Bad Company Into A Good One
06:56AM 03/27/13
-
Generic Drugmaker Mylan Is A Smart Healthcare Play
11:30PM 03/19/13
-
CareFusion's Technologies Meet Health Care Needs
06:30AM 02/13/13
-
Cramer's Top Stock Picks: HMST CCL CFN AAPL
06:00AM 02/09/13
-
Cramer's 'Mad Money' Recap: Next Week's Game Plan
08:13PM 02/08/13
-
CareFusion Management Discusses Q4 2012 Results - Earnings Call Transcript
09:20PM 08/09/12
Latest from TheStreet Wire
-
Medical Stock Hits New 52-Week High (MPW)
02:48PM 05/21/13
-
Panera Bread Stock Hits New 52-Week High (PNRA)
02:45PM 05/21/13
-
Owens-Illinois Reaches New 52-Week High (OI)
02:45PM 05/21/13
-
Dow Today: Pfizer (PFE) Higher Dow Today: Pfizer (PFE) Lower
02:39PM 05/21/13
-
Illinois Tool Works Reaches New 52-Week High (ITW)
02:38PM 05/21/13
-
Warner Chilcott Reaches New 52-Week High (WCRX)
02:09PM 05/21/13
-
American Express Reaches New 52-Week High (AXP)
02:02PM 05/21/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
